Gland Pharma receives FDA approval for Cangrelor for Injection 50 mg/vial
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), KENGREAL of Chiesi USA
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), KENGREAL of Chiesi USA
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
Glucagon is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus
Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
Divi's Laboratories has reported total income of Rs. 2,529 crores during the period ended June 30, 2025
Morepen Laboratories has reported total income of Rs. 429.64 crores during the period ended June 30, 2025
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
Quest will now offer dialysis-related clinical testing services to independent dialysis clinics
Caplin Point Laboratories has reported total income of Rs. 533.36 crores during the period ended June 30, 2025
Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
Subscribe To Our Newsletter & Stay Updated